首页 | 本学科首页   官方微博 | 高级检索  
检索        


Preclinical Imaging of Therapy Response Using Metabolic and Apoptosis Molecular Imaging
Authors:Marijke De Saint-Hubert  Huijun Wang  Ellen Devos  Kathleen Vunckx  Lin Zhou  Chris Reutelingsperger  Alfons Verbruggen  Luc Mortelmans  Yicheng Ni  Felix M Mottaghy
Institution:1.Department of Nuclear Medicine,University Hospital Gasthuisberg Leuven,Leuven,Belgium;2.Department of Radiology,University Hospital Gasthuisberg Leuven,Leuven,Belgium;3.Laboratory for Radiopharmacy, K.U. Leuven, O&N 2,Leuven,Belgium;4.Department of Biochemistry,University Maastricht,Maastricht,Netherlands;5.Klinik für Nuklearmedizin,Universit?tsklinikum der RWTH Aachen,Aachen,Germany;6.Department of Nuclear Medicine,Maastricht University Medical Centre,Maastricht,The Netherlands
Abstract:

Purpose  

Early after therapy, 2-deoxy-2-18F]fluoro-d-glucose (18F]FDG) imaging is not always reliable due to the influx of inflammatory cells while apoptosis imaging offers a direct and early measurement of therapy effects. This study uses an improved apoptosis probe (99mTc-hAnxA5) in combination with 18F]FDG imaging to evaluate therapy response.
Keywords:
本文献已被 SpringerLink 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号